The Hypertension-Diabetes Continuum

被引:55
|
作者
Cheung, Bernard M. Y. [1 ]
机构
[1] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China
关键词
blood pressure; blood glucose; hypertension; diabetes; dysglycemia; obesity; metabolic syndrome; IMPAIRED GLUCOSE-TOLERANCE; SYSTOLIC BLOOD-PRESSURE; HONG-KONG CHINESE; GENOME-WIDE SCAN; METABOLIC SYNDROME; INSULIN-RESISTANCE; SUSCEPTIBILITY LOCUS; LIFE-STYLE; PREVALENCE; RISK;
D O I
10.1097/FJC.0b013e3181d26430
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertension and type 2 diabetes are both common chronic conditions that affect a major proportion of the general population. They tend to occur in the same individual, suggesting common predisposing factors, which can be genetic or environmental. Although the genes causing hypertension or diabetes await elucidation, the environmental causes of these diseases are well known. Obesity and physical activity are the 2 leading factors that predispose to both diseases. Individuals with abdominal obesity are likely to develop lipid abnormalities and elevation of blood pressure and glucose. In time, hypertension and diabetes ensue. Because of the shared etiology, there is substantial overlap between hypertension and diabetes. In the Hong Kong Cardiovascular Risk Factor Prevalence Study, 40% of the subjects in the community had either raised blood pressure or raised blood glucose. Only 42% of people with diabetes had normal blood pressure and only 56% of people with hypertension had normal glucose tolerance. The presence of hypertension or diabetes should alert the clinician to the possibility of the other condition. Obesity, lipid abnormalities, raised blood pressure, and glucose are all components of the metabolic syndrome. The syndrome therefore implies a pathologic process, which is potentially reversible in the early stages. Previous efforts targeting smoking, hypertension, and hypercholesterolemia have started to bear fruit. However, obesity is on the increase in developed and developing countries. It is now time to focus on obesity and the metabolic syndrome, which require more a public health than a pharmacologic approach.
引用
收藏
页码:333 / 339
页数:7
相关论文
共 50 条
  • [31] Diabetes and hypertension
    Sayk, F.
    Iwen, K. A.
    Lehnert, H.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2009, 134 (45) : 2296 - 2301
  • [32] Hypertension in Reproductive-Aged Women With Polycystic Ovary Syndrome and Association With Obesity
    Joham, Anju E.
    Boyle, Jacqueline A.
    Zoungas, Sophia
    Teede, Helena J.
    AMERICAN JOURNAL OF HYPERTENSION, 2015, 28 (07) : 847 - 851
  • [33] Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition
    van den Berg, Esther
    Kloppenborg, Raoul P.
    Kessels, Roy P. C.
    Kappelle, L. Jaap
    Biessels, Geert Jan
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2009, 1792 (05): : 470 - 481
  • [34] Hypertension among the Inuit from Nunavik: should we expect an increase because of obesity?
    Chateau-Degat, Marie-Ludivine
    Dewailly, Eric
    Noel, Martin
    Valera, Beatriz
    Ferland, Annie
    Counil, Emilie
    Poirier, Paul
    Egeland, Grace M.
    INTERNATIONAL JOURNAL OF CIRCUMPOLAR HEALTH, 2010, 69 (04) : 361 - 372
  • [35] Salt Intake in Adults with Diabetes and Hypertension: The Longitudinal Study of Adult Health-Brasil Study
    Ribeiro, Natalia Goncalves
    Lelis, Deborah F.
    Griep, Rosane H.
    Barreto, Sandhi M.
    Molina, Maria del Carmen B.
    Schmidt, Maria I.
    Duncan, Bruce B.
    Bensenor, Isabela
    Lotufo, Paulo A.
    Mill, Jose G.
    Baldo, Marcelo Perim
    METABOLIC SYNDROME AND RELATED DISORDERS, 2024, 22 (05) : 356 - 364
  • [36] Incidence of type 2 diabetes, hypertension, and dyslipidemia in metabolically healthy obese and non-obese
    Fingeret, M.
    Marques-Vidal, R.
    Vollenweider, R.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2018, 28 (10) : 1036 - 1044
  • [37] Relationship between obesity indicators and hypertension-diabetes comorbidity in an elderly population: a retrospective cohort study
    Li, Haojie
    Shi, Zhan
    Chen, Xuejiao
    Wang, Junjie
    Ding, Jiacheng
    Geng, Shuoji
    Sheng, Xinyuan
    Shi, Songhe
    BMC GERIATRICS, 2023, 23 (01)
  • [38] Prevalence, Management, and Associated Factors of Obesity, Hypertension, and Diabetes in Tibetan Population Compared with China Overall
    Peng, Wen
    Li, Ke
    Yan, Alice F.
    Shi, Zumin
    Zhang, Junyi
    Cheskin, Lawrence J.
    Hussain, Ahktar
    Wang, Youfa
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (14)
  • [39] Mechanisms and pharmacotherapy of hypertension associated with type 2 diabetes
    Kamalumpundi, Vijayvardhan
    Shams, Elham
    Tucker, Cally
    Cheng, Linhai
    Peterson, Joshua
    Thangavel, Sanmati
    Ofori, Oloigbe
    Correia, Marcelo
    BIOCHEMICAL PHARMACOLOGY, 2022, 206
  • [40] Therapy of hypertension in patients with type 2 diabetes mellitus
    Hess, K.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (48) : 2489 - 2492